Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Goldman M&A head Sykes joins management committee

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2012 | 11:07pm CEST

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

The 54-year-old investment banker joins 28 other executives on the powerful committee, which includes Chief Executive Lloyd Blankfein and Chief Operating Officer Gary Cohn, and influences decisions about Goldman's business strategy and operations.

Sykes' appointment comes just nine days after the departure of another prominent Goldman banker, Yoel Zaoui, was announced in a separate internal memo. Zaoui shared the title of M&A co-head with Sykes and had also been on the management committee.

Sykes, who is based in Los Angeles, is also chairman of the global technology, media and telecommunications department of the investment banking division. He is a member of Goldman's internal Business Standards Committee.

The Goldman veteran joined the firm in 1984 and became a partner in 1992. He has advised on several high-profile deals, including Walt Disney Co's (>> The Walt Disney Company) acquisition of Pixar, Aetna Inc's (>> Aetna Inc.) acquisition of U.S. Healthcare and Roche Holding AG acquisition of Genentech.

"Gene has played a vital role in strengthening our investment banking franchise, particularly with respect to many of the most significant companies in technology and media," Blankfein and Cohn said in the memo, whose contents were confirmed by a spokesman.

(Reporting By Lauren Tara LaCapra in New York; editing by Andre Grenon)

By Lauren Tara LaCapra

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA INC
05/25DJInsurer Exit Leaves 25 Missouri Counties With No ACA Plans for 2018
05/24 AETNA INC /PA/ : Submission of Matters to a Vote of Security Holders, Financial ..
05/24 AETNA INC. (NYSE : AET) Files An 8-K Submission of Matters to a Vote of Security..
05/24DJHUMANA : Another Insurer Leaves Missouri's Affordable Care Act Exchange
05/24 AETNA : Recognizes 10 Employers For First Time Workplace Wellness Awards
05/19 AETNA INC /PA/ : Regulation FD Disclosure (form 8-K)
05/19 AETNA : Board of Directors Declares Quarterly Cash Dividend
05/19 INSIDER TRADING ACTIVITY AETNA INC ( : AET) – Chairman Sold 103,547 shares..
05/15 AETNA INC : Post Earnings Coverage as Aetna's Adjusted EPS Jumped 17%
05/12 AETNA INC : Blog Coverage: Obamacare Receives Another Jolt as Health Insurer Aet..
More news
Sector news : Managed Healthcare - NEC
05/25DJInsurer Exit Leaves 25 Missouri Counties With No ACA Plans for 2018
05/25DJCIGNA : to Give Each Employee Five Shares of Stock
05/24DJHUMANA : Another Insurer Leaves Missouri's Affordable Care Act Exchange
05/13DJANTHEM : Ends Cigna Pursuit -- WSJ
05/12DJANTHEM : Ends Cigna Pursuit, Plans to Seek Damages -- 2nd Update
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
05/26 Senate mulling toned-down version of healthcare plan
05/25 Seniors not on board with GOP's healthcare plan
05/25 Tracking Larry Robbins's Glenview Capital Management Portfolio - Q1 2017 Upda..
05/25 CBO evaluates new health bill
05/24 Aetna (AET) Presents At UBS Global Healthcare Conference 2017 - Slideshow
Advertisement
Financials ($)
Sales 2017 60 989 M
EBIT 2017 4 182 M
Net income 2017 1 838 M
Debt 2017 2 991 M
Yield 2017 1,01%
P/E ratio 2017 27,85
P/E ratio 2018 15,67
Capi. / Sales 2017 0,84x
Capi. / Sales 2018 0,75x
Capitalization 48 286 M
More Financials
Chart AETNA INC
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Full-screen chart
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 149 $
Spread / Average Target 2,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC17.39%48 286
UNITEDHEALTH GROUP INC10.91%171 050
ANTHEM INC27.34%48 514
CIGNA CORPORATION20.94%41 300
HUMANA INC13.83%33 517
CENTENE CORP31.96%12 847
More Results